ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAB1. A total of 11 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $687,000 | -89.0% | 570,000 | -88.6% | 0.01% | -89.0% |
| Q3 2018 | $6,235,000 | -7.0% | 5,000,000 | 0.0% | 0.07% | -16.1% |
| Q2 2018 | $6,707,000 | -74.4% | 5,000,000 | -74.6% | 0.09% | -74.3% |
| Q1 2018 | $26,166,000 | +166.0% | 19,685,000 | +125.9% | 0.34% | +238.0% |
| Q4 2017 | $9,838,000 | – | 8,715,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 12,355,000 | $14,956,000 | 1.86% |
| Redmile Group, LLC | 19,000,000 | $22,845,000 | 0.92% |
| LINDEN ADVISORS LP | 24,075,000 | $29,093,000 | 0.81% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 9,000,000 | $10,865,000 | 0.72% |
| CSS LLC/IL | 6,835,000 | $8,266,000 | 0.55% |
| Graham Capital Management, L.P. | 10,000,000 | $12,170,000 | 0.54% |
| Verition Fund Management LLC | 5,880,000 | $7,118,000 | 0.51% |
| SG Americas Securities, LLC | 120,000 | $14,527,000 | 0.13% |
| Nicholas Investment Partners, LP | 930,000 | $1,124,000 | 0.12% |
| OAKTREE CAPITAL MANAGEMENT LP | 6,000,000 | $7,262,000 | 0.07% |